Additional, we also found CRS can decrease the ATP5D expression in ileum and colon tissues, both low-dose and high-dose SNS treatments inhibited the decreased expression of ATP5D in the ileum and colon tissues (Figures 9A, B). This evidence concerns the gene ATP5F1D and congenital rubella syndrome.